Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease.
Mimee, Mark
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease.
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 11; 20(11):2427-2434.
View in:
PubMed
subject areas
Chronic Disease
Humans
Inflammatory Bowel Diseases
Minority Groups
Social Determinants of Health
United States
authors with profiles
David Rubin